The Lancet Oncology Q1 Unclaimed
Lancet Publishing Group
United Kingdom
The Lancet Oncology is a journal indexed in SJR in Oncology with an H index of 305. Journal with a Single blind Peer Review review system, and It has a price of 2395 €. The scope of the journal is focused on Oncology, Cancer, . It has an SJR impact factor of 15,65 and it has a best quartile of Q1. It is published in Western Europe.
Type: Journal
Type of Copyright:
Languages: Western Europe
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
Categories:
Oncology (Q1)
Price
2395 €
Gold OA-
Green OA0 €
Non OAMetrics
15,65
SJR Impact factor305
H Index618
Total Docs (Last Year)1958
Total Docs (3 years)8994
Total Refs18292
Total Cites (3 years)540
Citable Docs (3 years)31
Cites/Doc (2 years)14,55
Ref/DocAims and Scope
Oncology
Cancer
Other journals with similar parameters
Nature Reviews Clinical Oncology Q1
CA - A Cancer Journal for Clinicians Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of the National Cancer Institute Q1
If you are a journal editor you can claim the journal profile and add new information for the visitors.
Comments